Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suresh Thareja

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Chemical Reviews|March 19, 2015
Steroidal 5α-Reductase Inhibitors: A Comparative 3D-QSAR Study ReviewSuresh Thareja
Medical Oncology (Northwood, London, England)|May 16, 2023
Elacestrant: a new FDA-approved SERD for the treatment of breast cancerNeha Bhatia, Suresh Thareja
Anti-Cancer Agents in Medicinal Chemistry|August 18, 2025
Gaussian-based 3D-QSAR and Pharmacophore Mapping Studies of Indole Derivatives as Aromatase InhibitorsNeha Bhatia, Suresh Thareja
Chemistry & Biodiversity|June 30, 2026
Structure-Based De Novo Design of Novel Dual DPP IV and PTP 1B Inhibitors (DDPI's)Yogesh Singh, Suresh Thareja
Bioorganic Chemistry|July 13, 2024
Aromatase inhibitors for the treatment of breast cancer: An overview (2019-2023)Neha Bhatia, Suresh Thareja
Anti-Cancer Agents in Medicinal Chemistry|January 9, 2026
Molecular Simulation, Pharmacophore Mapping, and 3D QSAR Modeling on Chromene-Based SERDsSuresh Thareja, Sanjana Bisht
Plos One|April 12, 2017
Structure based comprehensive modelling, spatial fingerprints mapping and ADME screening of curcumin analogues as novel ALR2 inhibitorsSant Kumar Verma, Suresh Thareja
Artificial Cells, Nanomedicine, and Biotechnology|February 21, 2019
In vitro and in vivo characterization of pharmaceutical nanocarriers used for drug deliveryAkhlesh K Jain, Suresh Thareja
Mini Reviews in Medicinal Chemistry|March 1, 2026
Inavolisib-based Combination Therapy for the Treatment of PIK3CAMutated HR+/HER2- Breast Cancer: An OverviewSushmita Bhatia, Neha Bhatia, Suresh Thareja
European Journal of Medicinal Chemistry|May 10, 2023
Selective Estrogen receptor degraders (SERDs) for the treatment of breast cancer: An overviewNeha Bhatia, Shreejita Hazra, Suresh Thareja
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Chemical Reviews|March 19, 2015
Steroidal 5α-Reductase Inhibitors: A Comparative 3D-QSAR Study ReviewSuresh Thareja
Medical Oncology (Northwood, London, England)|May 16, 2023
Elacestrant: a new FDA-approved SERD for the treatment of breast cancerNeha Bhatia, Suresh Thareja
Anti-Cancer Agents in Medicinal Chemistry|August 18, 2025
Gaussian-based 3D-QSAR and Pharmacophore Mapping Studies of Indole Derivatives as Aromatase InhibitorsNeha Bhatia, Suresh Thareja
Chemistry & Biodiversity|June 30, 2026
Structure-Based De Novo Design of Novel Dual DPP IV and PTP 1B Inhibitors (DDPI's)Yogesh Singh, Suresh Thareja
Bioorganic Chemistry|July 13, 2024
Aromatase inhibitors for the treatment of breast cancer: An overview (2019-2023)Neha Bhatia, Suresh Thareja
Anti-Cancer Agents in Medicinal Chemistry|January 9, 2026
Molecular Simulation, Pharmacophore Mapping, and 3D QSAR Modeling on Chromene-Based SERDsSuresh Thareja, Sanjana Bisht
Plos One|April 12, 2017
Structure based comprehensive modelling, spatial fingerprints mapping and ADME screening of curcumin analogues as novel ALR2 inhibitorsSant Kumar Verma, Suresh Thareja
Artificial Cells, Nanomedicine, and Biotechnology|February 21, 2019
In vitro and in vivo characterization of pharmaceutical nanocarriers used for drug deliveryAkhlesh K Jain, Suresh Thareja
Mini Reviews in Medicinal Chemistry|March 1, 2026
Inavolisib-based Combination Therapy for the Treatment of PIK3CAMutated HR+/HER2- Breast Cancer: An OverviewSushmita Bhatia, Neha Bhatia, Suresh Thareja
European Journal of Medicinal Chemistry|May 10, 2023
Selective Estrogen receptor degraders (SERDs) for the treatment of breast cancer: An overviewNeha Bhatia, Shreejita Hazra, Suresh Thareja
Pageof 10